Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19

Allergy. 2021 Mar;76(3):626-628. doi: 10.1111/all.14595.
No abstract available

Keywords: COVID-19; SARS-CoV-2; dexamethasone; hyperinflammation; proresolving lipids.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / immunology
  • COVID-19 Drug Treatment*
  • Dexamethasone / pharmacology*
  • Dexamethasone / therapeutic use
  • Docosahexaenoic Acids / physiology*
  • Fatty Acids, Unsaturated / physiology*
  • Humans
  • Inflammation / drug therapy*
  • SARS-CoV-2*

Substances

  • Fatty Acids, Unsaturated
  • protectin D1
  • resolvin D4
  • Docosahexaenoic Acids
  • Dexamethasone